Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease

M. Bradley Drummond, Nadia Hansel, John E. Connett, Paul D. Scanlon, Donald P. Tashkin, Robert A Wise

Research output: Contribution to journalArticle

Abstract

Rationale: The course of lung function decline for smokers with early airflow obstruction remains undefined. It is also unclear which early spirometric characteristics identify individuals at risk for rapid decline and increased mortality. Objectives: To determine the association between spirometric measures and 5-year decline in FEV1 and 12-year mortality. Methods: We analyzed longitudinal data from the Lung Health Study, a clinical trial of intensive smoking cessation intervention with or without bronchodilator therapy in 5,887 smokers with mild to moderate airflow obstruction. Participants were stratified into bins of baseline FEV1 to FVC ratio, using bins of 5%, and separately into bins of Z-score (difference between actual and predicted FEV1/FVC, normalized to SD of predicted FEV1/FVC). Associations between spirometric measures and FEV1 decline and mortality were determined after adjusting for baseline characteristics and time-varying smoking status. Measurements and Main Results: The cohort was approximately two-thirds male, predominantly of white race (96%), and with mean age of 49 ± 7 years. In general, individuals with lower lung function by any metric had more rapid adjusted FEV1 decline. A threshold for differential decline was present at FEV1/FVC less than 0.65 (P <0.001) and Z-score less than -2 (2.3 percentile) (P <0.001). At year 12, 575 (7.2%) of the cohort had died. Lower thresholds of each spirometric metric were associated with increasing adjusted hazard of death. Conclusions: Smokers at risk or with mild to moderate chronic obstructive pulmonary disease have accelerated lung function decline. Individuals with lower baseline FEV1/FVC have more rapid decline and worse mortality.

Original languageEnglish (US)
Pages (from-to)1301-1306
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume185
Issue number12
DOIs
StatePublished - Jun 15 2012

Fingerprint

Chronic Obstructive Pulmonary Disease
Lung
Mortality
Differential Threshold
Bronchodilator Agents
Smoking Cessation
Smoking
Clinical Trials
Health
Therapeutics

Keywords

  • Chronic obstructive pulmonary disease
  • Disease progression
  • Mortality
  • Prognosis
  • Spirometry

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. / Drummond, M. Bradley; Hansel, Nadia; Connett, John E.; Scanlon, Paul D.; Tashkin, Donald P.; Wise, Robert A.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 185, No. 12, 15.06.2012, p. 1301-1306.

Research output: Contribution to journalArticle

@article{defd72a9be57497483cff84e37bc4d9c,
title = "Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease",
abstract = "Rationale: The course of lung function decline for smokers with early airflow obstruction remains undefined. It is also unclear which early spirometric characteristics identify individuals at risk for rapid decline and increased mortality. Objectives: To determine the association between spirometric measures and 5-year decline in FEV1 and 12-year mortality. Methods: We analyzed longitudinal data from the Lung Health Study, a clinical trial of intensive smoking cessation intervention with or without bronchodilator therapy in 5,887 smokers with mild to moderate airflow obstruction. Participants were stratified into bins of baseline FEV1 to FVC ratio, using bins of 5{\%}, and separately into bins of Z-score (difference between actual and predicted FEV1/FVC, normalized to SD of predicted FEV1/FVC). Associations between spirometric measures and FEV1 decline and mortality were determined after adjusting for baseline characteristics and time-varying smoking status. Measurements and Main Results: The cohort was approximately two-thirds male, predominantly of white race (96{\%}), and with mean age of 49 ± 7 years. In general, individuals with lower lung function by any metric had more rapid adjusted FEV1 decline. A threshold for differential decline was present at FEV1/FVC less than 0.65 (P <0.001) and Z-score less than -2 (2.3 percentile) (P <0.001). At year 12, 575 (7.2{\%}) of the cohort had died. Lower thresholds of each spirometric metric were associated with increasing adjusted hazard of death. Conclusions: Smokers at risk or with mild to moderate chronic obstructive pulmonary disease have accelerated lung function decline. Individuals with lower baseline FEV1/FVC have more rapid decline and worse mortality.",
keywords = "Chronic obstructive pulmonary disease, Disease progression, Mortality, Prognosis, Spirometry",
author = "Drummond, {M. Bradley} and Nadia Hansel and Connett, {John E.} and Scanlon, {Paul D.} and Tashkin, {Donald P.} and Wise, {Robert A}",
year = "2012",
month = "6",
day = "15",
doi = "10.1164/rccm.201202-0223OC",
language = "English (US)",
volume = "185",
pages = "1301--1306",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "12",

}

TY - JOUR

T1 - Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease

AU - Drummond, M. Bradley

AU - Hansel, Nadia

AU - Connett, John E.

AU - Scanlon, Paul D.

AU - Tashkin, Donald P.

AU - Wise, Robert A

PY - 2012/6/15

Y1 - 2012/6/15

N2 - Rationale: The course of lung function decline for smokers with early airflow obstruction remains undefined. It is also unclear which early spirometric characteristics identify individuals at risk for rapid decline and increased mortality. Objectives: To determine the association between spirometric measures and 5-year decline in FEV1 and 12-year mortality. Methods: We analyzed longitudinal data from the Lung Health Study, a clinical trial of intensive smoking cessation intervention with or without bronchodilator therapy in 5,887 smokers with mild to moderate airflow obstruction. Participants were stratified into bins of baseline FEV1 to FVC ratio, using bins of 5%, and separately into bins of Z-score (difference between actual and predicted FEV1/FVC, normalized to SD of predicted FEV1/FVC). Associations between spirometric measures and FEV1 decline and mortality were determined after adjusting for baseline characteristics and time-varying smoking status. Measurements and Main Results: The cohort was approximately two-thirds male, predominantly of white race (96%), and with mean age of 49 ± 7 years. In general, individuals with lower lung function by any metric had more rapid adjusted FEV1 decline. A threshold for differential decline was present at FEV1/FVC less than 0.65 (P <0.001) and Z-score less than -2 (2.3 percentile) (P <0.001). At year 12, 575 (7.2%) of the cohort had died. Lower thresholds of each spirometric metric were associated with increasing adjusted hazard of death. Conclusions: Smokers at risk or with mild to moderate chronic obstructive pulmonary disease have accelerated lung function decline. Individuals with lower baseline FEV1/FVC have more rapid decline and worse mortality.

AB - Rationale: The course of lung function decline for smokers with early airflow obstruction remains undefined. It is also unclear which early spirometric characteristics identify individuals at risk for rapid decline and increased mortality. Objectives: To determine the association between spirometric measures and 5-year decline in FEV1 and 12-year mortality. Methods: We analyzed longitudinal data from the Lung Health Study, a clinical trial of intensive smoking cessation intervention with or without bronchodilator therapy in 5,887 smokers with mild to moderate airflow obstruction. Participants were stratified into bins of baseline FEV1 to FVC ratio, using bins of 5%, and separately into bins of Z-score (difference between actual and predicted FEV1/FVC, normalized to SD of predicted FEV1/FVC). Associations between spirometric measures and FEV1 decline and mortality were determined after adjusting for baseline characteristics and time-varying smoking status. Measurements and Main Results: The cohort was approximately two-thirds male, predominantly of white race (96%), and with mean age of 49 ± 7 years. In general, individuals with lower lung function by any metric had more rapid adjusted FEV1 decline. A threshold for differential decline was present at FEV1/FVC less than 0.65 (P <0.001) and Z-score less than -2 (2.3 percentile) (P <0.001). At year 12, 575 (7.2%) of the cohort had died. Lower thresholds of each spirometric metric were associated with increasing adjusted hazard of death. Conclusions: Smokers at risk or with mild to moderate chronic obstructive pulmonary disease have accelerated lung function decline. Individuals with lower baseline FEV1/FVC have more rapid decline and worse mortality.

KW - Chronic obstructive pulmonary disease

KW - Disease progression

KW - Mortality

KW - Prognosis

KW - Spirometry

UR - http://www.scopus.com/inward/record.url?scp=84862582008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862582008&partnerID=8YFLogxK

U2 - 10.1164/rccm.201202-0223OC

DO - 10.1164/rccm.201202-0223OC

M3 - Article

VL - 185

SP - 1301

EP - 1306

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 12

ER -